NovaBridge Biosciences American Depositary Shares
NBP
96 hedge funds and large institutions have $431M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 36 reducing their positions, and 38 closing their positions.
4.2% less ownership
Funds ownership: 50.43% → 46.23% (-4.2%)
19% less funds holding
Funds holding: 119 → 96 (-23)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
25% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 36
34% less capital invested
Capital invested by funds: $657M → $431M (-$226M)
46% less call options, than puts
Call options by funds: $1.21M | Put options by funds: $2.24M
58% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$39.8M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$31.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.4M |
| 4 |
Morgan Stanley
New York
|
+$9.01M |
| 5 |
Goldman Sachs
New York
|
+$4.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$53.3M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$11M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$10.2M |
| 4 |
BlackRock
New York
|
-$9.18M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.99M |
NBP Hedge Fund Activity: Q2 2022 in Review
96 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2022, worth a combined $431M — down 34% from $657M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of NBP and 16 opened new positions — a net loss of 22 holders — while 36 trimmed existing stakes and 27 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $39.8M. The largest seller was T. Rowe Price Associates, cutting an estimated $53.3M.
- 96 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2022, down from 119 in Q1 2022.
- Funds reported $431M of NovaBridge Biosciences American Depositary Shares stock for Q2 2022, down 34% quarter-over-quarter.
- 16 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2022 and 38 closed out, a net change of -22 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2022 was Armistice Capital, an estimated $39.8M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2022 was T. Rowe Price Associates, an estimated $53.3M sold.
Based on aggregated 13F filings for Q2 2022.